IDEAS home Printed from https://ideas.repec.org/a/plo/pgph00/0001309.html
   My bibliography  Save this article

Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings

Author

Listed:
  • Trishul Siddharthan
  • Nicole M Robertson
  • Natalie A Rykiel
  • Lindsay J Underhill
  • Nihaal Rahman
  • Sujan Kafle
  • Sakshi Mohan
  • Roma Padalkar
  • Sarah McKeown
  • Oscar Flores-Flores
  • Shumonta A Quaderi
  • Patricia Alupo
  • Robert Kalyesubula
  • Bruce Kirenga
  • Jing Luo
  • Maria Kathia Cárdenas
  • Gonzalo Gianella
  • J Jaime Miranda
  • William Checkley
  • John R Hurst
  • Suzanne L Pollard

Abstract

Introduction: Despite the rising burden of chronic respiratory disease globally, and although many respiratory medications are included in the World Health Organization Essential Medications List (WHO-EML), there is limited information concerning the availability and affordability of treatment drugs for respiratory conditions in low- and middle-income countries (LMICs). Methods: All public and private pharmacies in catchment areas of the Global Excellence in COPD outcomes (GECo) study sites in Bhaktapur, Nepal, Lima, Peru, and Nakaseke, Uganda, were approached in 2017–2019 to assess pricing and availability of medications for the management of asthma and COPD. Results: We surveyed all 63 pharmacies in respective study areas in Nepal (95.2% private), 104 pharmacies in Peru (94.2% private) and 53 pharmacies in Uganda (98.1% private). The availability of any medication for respiratory disease was higher in private (93.3%) compared to public (73.3%) pharmacies. Salbutamol (WHO-EML) monotherapy in any formulation was the most commonly available respiratory medication among the three sites (93.7% Nepal, 86.5% Peru and 79.2% Uganda) while beclomethasone (WHO-EML) was only available in Peru (33.7%) and Nepal (22%). LABA-LAMA combination therapy was only available in Nepal (14.3% of pharmacies surveyed). The monthly treatment cost of respiratory medications was lowest in Nepal according to several cost metrics: the overall monthly cost, the median price ratio comparing medication costs to international reference prices at time of survey in dollars, and in terms of days’ wages of the lowest-paid government worker. For the treatment of intermittent asthma, defined as 100 mcg Salbutamol/Albuterol inhaler, days’ wages ranged from 0.47 days in Nepal and Peru to 3.33 days in Uganda. Conclusion: The availability and pricing of respiratory medications varied across LMIC settings, with medications for acute care of respiratory diseases being more widely available than those for long-term management.

Suggested Citation

  • Trishul Siddharthan & Nicole M Robertson & Natalie A Rykiel & Lindsay J Underhill & Nihaal Rahman & Sujan Kafle & Sakshi Mohan & Roma Padalkar & Sarah McKeown & Oscar Flores-Flores & Shumonta A Quader, 2022. "Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings," PLOS Global Public Health, Public Library of Science, vol. 2(12), pages 1-14, December.
    • Handle: RePEc:plo:pgph00:0001309
    DOI: 10.1371/journal.pgph.0001309
    as

    Download full text from publisher

    File URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001309
    Download Restriction: no
    File URL: https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001309&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pgph.0001309?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Zaheer-Ud-Din Babar & Charon Lessing & Cécile Mace & Karen Bissell, 2013. "The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 31(11), pages 1063-1082, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Karen Bissell & Philippa Ellwood & Eamon Ellwood & Chen-Yuan Chiang & Guy B. Marks & Asma El Sony & Innes Asher & Nils Billo & Christophe Perrin & the Global Asthma Network Study Group, 2019. "Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014," IJERPH, MDPI, vol. 16(4), pages 1-15, February.
    2. Felix Khuluza & Lutz Heide, 2017. "Availability and affordability of antimalarial and antibiotic medicines in Malawi," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-15, April.
    3. Boniface Ayanbekongshie Ushie & David Betelwhobel Ugal & Justin Agorye Ingwu, 2016. "Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-13, November.
    4. May Chien Chin & Sheamini Sivasampu & Ee Ming Khoo, 2017. "Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-12, June.
    5. Yan Song & Ying Bian & Tianmin Zhen, 2018. "Making medicines more accessible in China: An empirical study investigating the early progress of essential medicine system," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-13, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pgph00:0001309. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: globalpubhealth (email available below). General contact details of provider: https://journals.plos.org/globalpublichealth .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.